1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Torres, A.M.
De Plater, G.M.
Doverskog, M.
C Birinyi-Strachan, L.
Nicholson, G.M.
Gallagher, C.H.
Kuchel, P.W.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Biochem.J.
BIJOAK
0043
0264-6021
348
649
656
10.1042/0264-6021:3480649
10839998
Defensin-like peptide-2 from platypus venom: member of a class of peptides with a distinct structural fold.
2000
UK
Biochem.J.
BIJOAK
0043
0264-6021
341
785
794
10.1042/0264-6021:3410785
Solution Structure of a Defensin-Like Peptide From Platypus Venom
1999
US
Biochemistry
BICHAW
0033
0006-2960
34
13663
13671
Solution Structure of Bovine Neutrophil Beta-Defensin-12: The Peptide Fold of the Beta-Defensins is Identical to That of the Classical Defensins
1995
10.2210/pdb1d6b/pdb
pdb_00001d6b
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
5121.899
DEFENSIN-LIKE PEPTIDE-2
1
nat
polymer
no
no
IMFFEMQACWSHSGVCRDKSERNCKPMAWTYCENRNQKCCEY
IMFFEMQACWSHSGVCRDKSERNCKPMAWTYCENRNQKCCEY
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
platypus
Ornithorhynchus
sample
9258
SPUR
Ornithorhynchus anatinus
VENOM
VENOM GLAND
database_2
pdbx_nmr_software
pdbx_nmr_spectrometer
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2000-06-21
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-16
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_pdbx_nmr_spectrometer.model
RCSB
Y
RCSB
1999-10-12
REL
REL
THE STRUCTURES WERE DETERMINED USING STANDARD 2D HOMONUCLEAR TECHNIQUES.
LOWEST ENERGY
4800
20
2D NOESY
NO SALT ADDED
3.6
AMBIENT
298
K
THE STRUCTURES ARE BASED ON A TOTAL OF 739 RESTRAINTS, 699 ARE NOE-DERIVED
DISTANCE RESTRAINTS, 24 DIHEDRAL ANGLE RESTRAINTS, 16 DISTANCE RESTRAINTS FROM
HYDROGEN BONDS.
DISTANCE GEOMETRY, SIMULATED ANNEALING, MOLECULAR DYNAMICS, TORSION ANGLE
DYNAMICS
1
lowest energy
1MM DLP-2
BRUKER
processing
XwinNMR
2.5
BARTELS, C., XIA, T., BILLETER, M., GUNTERT, P., WUTHRICH, K.
data analysis
XEASY
1.3.13
GUNTERT, P., MUMENTHALER, C., WUHTRICH, K.
structure solution
DYANA
1.5
BRUNGER
refinement
X-PLOR
3.843
600
Bruker
AVANCE
ILE
1
n
1
ILE
1
A
MET
2
n
2
MET
2
A
PHE
3
n
3
PHE
3
A
PHE
4
n
4
PHE
4
A
GLU
5
n
5
GLU
5
A
MET
6
n
6
MET
6
A
GLN
7
n
7
GLN
7
A
ALA
8
n
8
ALA
8
A
CYS
9
n
9
CYS
9
A
TRP
10
n
10
TRP
10
A
SER
11
n
11
SER
11
A
HIS
12
n
12
HIS
12
A
SER
13
n
13
SER
13
A
GLY
14
n
14
GLY
14
A
VAL
15
n
15
VAL
15
A
CYS
16
n
16
CYS
16
A
ARG
17
n
17
ARG
17
A
ASP
18
n
18
ASP
18
A
LYS
19
n
19
LYS
19
A
SER
20
n
20
SER
20
A
GLU
21
n
21
GLU
21
A
ARG
22
n
22
ARG
22
A
ASN
23
n
23
ASN
23
A
CYS
24
n
24
CYS
24
A
LYS
25
n
25
LYS
25
A
PRO
26
n
26
PRO
26
A
MET
27
n
27
MET
27
A
ALA
28
n
28
ALA
28
A
TRP
29
n
29
TRP
29
A
THR
30
n
30
THR
30
A
TYR
31
n
31
TYR
31
A
CYS
32
n
32
CYS
32
A
GLU
33
n
33
GLU
33
A
ASN
34
n
34
ASN
34
A
ARG
35
n
35
ARG
35
A
ASN
36
n
36
ASN
36
A
GLN
37
n
37
GLN
37
A
LYS
38
n
38
LYS
38
A
CYS
39
n
39
CYS
39
A
CYS
40
n
40
CYS
40
A
GLU
41
n
41
GLU
41
A
TYR
42
n
42
TYR
42
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
ARG
17
A
O
ARG
17
A
N
LYS
38
A
N
LYS
38
1
A
A
HG2
HB2
GLU
CYS
21
24
1.18
1
A
A
HG3
H
GLU
ASN
21
23
1.25
1
A
A
HG12
H
VAL
CYS
15
16
1.28
3
A
A
HG2
HB2
GLU
CYS
21
24
1.19
3
A
A
HB3
H
MET
GLN
6
7
1.28
3
A
A
HA
HE2
CYS
HIS
9
12
1.32
3
A
A
HG3
H
GLU
ASN
21
23
1.33
4
A
A
HG3
H
GLU
ASN
21
23
1.23
4
A
A
HA
HG3
LYS
LYS
19
38
1.24
5
A
A
HG2
HB2
GLU
CYS
21
24
1.16
5
A
A
HG3
H
GLU
ASN
21
23
1.22
5
A
A
OE2
O
GLU
ASN
21
23
2.18
6
A
A
HG2
HB2
GLU
CYS
21
24
1.19
6
A
A
HG3
H
GLU
ASN
21
23
1.28
6
A
A
OE2
O
GLU
ASN
21
23
2.17
7
A
A
HG3
HB2
LYS
GLU
25
41
1.28
9
A
A
HB3
HD3
LYS
LYS
19
38
1.20
9
A
A
HE2
HA
MET
GLU
27
41
1.20
9
A
A
HB2
H
LYS
GLU
25
41
1.22
11
A
A
HD21
H
ASN
ASN
34
36
1.26
12
A
A
HB3
H
PHE
PHE
3
4
1.26
13
A
A
HB3
HZ1
CYS
LYS
24
38
1.34
14
A
A
HB2
HB2
CYS
CYS
16
32
1.34
17
A
A
HB2
H
LYS
GLU
25
41
1.18
17
A
A
HD3
H
LYS
SER
19
20
1.28
18
A
A
H
HA
GLN
THR
7
30
1.22
18
A
A
HG3
HB3
LYS
GLU
25
41
1.26
18
A
A
HB2
HG23
GLN
THR
7
30
1.27
20
A
A
HG2
HG2
LYS
LYS
19
38
1.20
20
A
A
HG2
H
MET
THR
6
30
1.27
20
A
A
HB3
HB2
ASN
GLN
34
37
1.27
20
A
A
HG12
H
VAL
CYS
15
16
1.34
1
A
MET
2
70.75
-165.70
1
A
PHE
4
154.55
-119.04
1
A
GLU
5
13.82
84.26
1
A
MET
6
-43.99
-108.66
1
A
ALA
8
-23.11
115.83
1
A
SER
13
81.05
72.82
1
A
ASP
18
-35.54
133.30
1
A
ALA
28
-47.04
176.26
1
A
TRP
29
40.17
73.81
1
A
THR
30
159.14
137.01
1
A
ARG
35
-67.06
12.88
1
A
GLU
41
-50.69
-73.01
2
A
MET
2
-51.73
77.58
2
A
PHE
3
-137.50
-126.66
2
A
PHE
4
86.22
76.50
2
A
GLU
5
-1.85
69.28
2
A
MET
6
-36.74
-93.83
2
A
ALA
8
-21.78
129.69
2
A
PRO
26
-44.22
96.29
2
A
ALA
28
-62.71
-171.58
2
A
TRP
29
40.10
75.44
2
A
THR
30
162.88
157.49
2
A
ARG
35
-60.12
17.52
2
A
GLU
41
-42.63
-74.01
3
A
PHE
3
-102.22
65.29
3
A
MET
6
-52.91
-134.66
3
A
ALA
8
-30.80
103.35
3
A
CYS
9
-31.20
-25.95
3
A
SER
13
61.78
77.43
3
A
PRO
26
-47.66
99.92
3
A
ALA
28
-52.44
177.58
3
A
TRP
29
39.76
72.89
3
A
THR
30
165.11
150.06
3
A
ARG
35
-64.99
12.48
3
A
GLU
41
-56.24
-76.10
4
A
PHE
4
67.32
109.89
4
A
GLU
5
170.70
83.45
4
A
MET
6
-54.60
-138.70
4
A
GLN
7
-127.18
-149.59
4
A
CYS
9
-33.60
-24.60
4
A
SER
11
-56.30
10.05
4
A
SER
13
89.51
65.51
4
A
PRO
26
-52.86
108.49
4
A
MET
27
-103.39
76.15
4
A
ALA
28
-46.54
-166.74
4
A
TRP
29
36.34
66.11
4
A
THR
30
153.09
147.87
4
A
ARG
35
-66.52
15.65
5
A
PHE
3
-98.49
39.46
5
A
PHE
4
-93.90
56.51
5
A
MET
6
-50.01
-157.35
5
A
ALA
8
-35.11
126.08
5
A
PRO
26
-37.13
110.19
5
A
ALA
28
-51.62
-176.41
5
A
TRP
29
37.43
72.16
5
A
THR
30
160.72
133.25
5
A
TYR
31
-117.84
-169.93
5
A
GLU
41
-51.53
-72.14
6
A
MET
2
44.19
99.87
6
A
PHE
4
18.13
81.14
6
A
GLU
5
162.30
122.36
6
A
MET
6
-77.79
-126.96
6
A
SER
13
39.29
63.42
6
A
ASP
18
-30.80
148.52
6
A
PRO
26
-37.68
99.19
6
A
ALA
28
-66.09
-174.08
6
A
TRP
29
37.84
74.63
6
A
THR
30
154.55
148.60
6
A
GLU
41
-50.70
-90.94
7
A
MET
2
88.13
151.47
7
A
PHE
3
-145.09
-85.94
7
A
PHE
4
-144.11
-139.29
7
A
GLU
5
48.40
100.53
7
A
MET
6
-66.63
-113.07
7
A
ALA
8
-29.22
118.61
7
A
SER
13
40.02
73.71
7
A
ASP
18
-35.67
133.33
7
A
LYS
25
-39.43
102.69
7
A
PRO
26
-58.90
107.59
7
A
TRP
29
39.09
72.91
7
A
THR
30
165.65
145.13
8
A
PHE
3
-119.94
-99.59
8
A
GLU
5
171.10
50.61
8
A
MET
6
-67.93
-99.06
8
A
SER
13
72.40
76.67
8
A
ARG
17
-128.48
-166.28
8
A
LYS
19
-58.95
15.27
8
A
GLU
21
-36.24
148.65
8
A
ASN
23
-141.94
44.04
8
A
PRO
26
-42.16
108.11
8
A
ALA
28
-54.96
-170.67
8
A
TRP
29
40.21
74.03
8
A
THR
30
160.41
157.33
9
A
MET
2
24.80
88.56
9
A
PHE
4
-27.26
88.08
9
A
GLU
5
170.89
119.69
9
A
MET
6
-69.18
-119.76
9
A
ALA
8
-23.43
105.56
9
A
CYS
9
-29.78
-28.98
9
A
SER
13
83.61
64.60
9
A
SER
20
-60.47
10.30
9
A
LYS
25
-51.44
99.33
9
A
PRO
26
-41.99
93.50
9
A
TRP
29
37.87
73.04
9
A
THR
30
172.79
135.52
10
A
PHE
4
-71.18
37.64
10
A
GLU
5
-99.90
59.03
10
A
MET
6
-59.52
-113.33
10
A
ALA
8
-23.50
139.95
10
A
SER
13
25.60
61.85
10
A
ASP
18
-30.33
127.66
10
A
LYS
19
-43.82
-13.77
10
A
ASN
23
-109.51
71.16
10
A
LYS
25
-55.57
109.83
10
A
PRO
26
-40.92
94.89
10
A
ALA
28
-56.99
-168.93
10
A
TRP
29
39.90
74.30
10
A
THR
30
162.89
148.11
10
A
CYS
32
-109.38
-162.21
11
A
PHE
4
-162.38
58.40
11
A
GLU
5
-166.87
91.54
11
A
MET
6
-74.98
-150.54
11
A
GLN
7
-141.89
-125.11
11
A
CYS
9
-35.62
-25.36
11
A
SER
11
-48.61
-19.77
11
A
SER
13
82.32
70.23
11
A
ASP
18
-35.47
134.20
11
A
LYS
25
-57.25
102.22
11
A
PRO
26
-43.64
98.72
11
A
MET
27
-105.54
78.11
11
A
ALA
28
-48.68
-171.06
11
A
TRP
29
38.34
73.83
11
A
THR
30
159.41
142.36
11
A
CYS
32
-111.56
-159.36
11
A
GLU
41
-29.73
-55.85
12
A
MET
2
-20.17
141.06
12
A
PHE
3
-124.12
-125.77
12
A
PHE
4
-158.25
12.73
12
A
GLU
5
-107.57
59.98
12
A
MET
6
-70.50
-100.77
12
A
ALA
8
-32.91
120.37
12
A
CYS
9
-33.63
-28.44
12
A
SER
11
-36.56
-32.62
12
A
SER
13
76.33
81.87
12
A
LYS
19
-49.65
-4.14
12
A
CYS
24
-107.61
78.92
12
A
LYS
25
-47.08
104.09
12
A
PRO
26
-45.85
100.90
12
A
ALA
28
-65.51
-179.87
12
A
TRP
29
37.16
71.49
12
A
THR
30
162.69
136.69
12
A
ARG
35
-58.33
14.90
12
A
GLU
41
-30.77
-84.40
13
A
PHE
3
-126.48
-124.70
13
A
GLU
5
-160.87
106.78
13
A
MET
6
-55.71
-111.44
13
A
ALA
8
-32.48
114.58
13
A
CYS
9
-36.29
-28.05
13
A
SER
11
-39.35
-26.87
13
A
SER
13
78.84
67.71
13
A
LYS
19
-31.51
-37.08
13
A
SER
20
-78.15
21.56
13
A
ASN
23
-116.69
69.83
13
A
LYS
25
-42.85
104.74
13
A
PRO
26
-45.44
98.55
13
A
ALA
28
-57.09
-175.37
13
A
TRP
29
37.78
73.50
13
A
THR
30
160.38
138.08
13
A
ARG
35
-63.40
11.59
13
A
GLU
41
-41.58
-72.60
14
A
PHE
4
-167.45
-128.94
14
A
GLU
5
64.01
108.19
14
A
MET
6
-70.49
-166.11
14
A
SER
13
59.32
78.12
14
A
ASP
18
-32.91
140.31
14
A
LYS
19
-59.36
8.42
14
A
LYS
25
-58.65
100.73
14
A
PRO
26
-43.41
95.38
14
A
ALA
28
-50.15
-168.98
14
A
TRP
29
34.31
66.73
14
A
THR
30
150.21
140.42
14
A
TYR
31
-112.07
-158.94
14
A
ARG
35
-61.91
17.62
15
A
MET
2
69.21
64.31
15
A
PHE
3
-93.55
-80.75
15
A
PHE
4
-108.23
-153.61
15
A
GLU
5
66.38
106.89
15
A
MET
6
-59.64
-154.93
15
A
ALA
8
-12.79
110.66
15
A
CYS
9
-26.59
-32.02
15
A
SER
11
-49.53
3.92
15
A
SER
13
91.99
70.63
15
A
LYS
19
-58.38
-1.47
15
A
PRO
26
-48.82
99.25
15
A
TRP
29
36.85
71.78
15
A
ARG
35
-67.21
16.17
15
A
GLU
41
-26.12
-55.41
16
A
MET
2
175.47
-149.27
16
A
PHE
3
-149.00
-127.45
16
A
PHE
4
28.39
52.23
16
A
GLU
5
-157.93
67.04
16
A
MET
6
-62.07
-155.96
16
A
CYS
9
-35.29
-25.29
16
A
SER
11
-29.86
-27.24
16
A
SER
13
85.85
80.09
16
A
ASP
18
-29.77
134.71
16
A
LYS
19
-60.90
12.27
16
A
PRO
26
-41.03
103.29
16
A
ALA
28
-56.08
-176.44
16
A
TRP
29
36.25
72.56
16
A
THR
30
152.80
145.61
16
A
CYS
32
-100.65
-169.63
16
A
ARG
35
-60.07
14.90
16
A
GLU
41
-53.84
-82.40
17
A
PHE
3
-134.62
-65.25
17
A
MET
6
-96.34
-155.17
17
A
ALA
8
-27.47
121.95
17
A
SER
11
-51.80
-3.43
17
A
SER
13
29.72
64.46
17
A
ASP
18
-39.51
140.07
17
A
LYS
25
-58.21
105.79
17
A
PRO
26
-44.99
86.48
17
A
ALA
28
-66.57
-172.58
17
A
TRP
29
38.43
73.91
17
A
THR
30
172.68
146.15
18
A
PHE
4
-46.50
75.38
18
A
MET
6
-56.71
-172.98
18
A
ALA
8
-43.14
109.61
18
A
CYS
9
-29.32
-28.17
18
A
SER
11
-49.40
1.15
18
A
SER
13
77.41
71.86
18
A
LYS
19
-48.89
-2.31
18
A
ASN
23
-114.35
70.50
18
A
LYS
25
-54.98
106.74
18
A
PRO
26
-50.28
108.66
18
A
ALA
28
-75.64
-156.45
18
A
TRP
29
21.28
39.91
18
A
ARG
35
-61.89
7.18
19
A
MET
2
69.76
139.66
19
A
GLU
5
-107.02
75.04
19
A
MET
6
-79.65
-115.40
19
A
ALA
8
-37.67
115.13
19
A
CYS
9
-33.11
-33.04
19
A
SER
11
-60.06
0.67
19
A
PRO
26
-50.19
99.23
19
A
TRP
29
38.13
74.49
19
A
THR
30
162.73
153.34
20
A
MET
2
23.96
52.78
20
A
PHE
3
-145.52
-13.63
20
A
PHE
4
73.19
49.18
20
A
GLU
5
-103.43
46.16
20
A
MET
6
-48.55
-173.61
20
A
ALA
8
-33.35
117.25
20
A
CYS
9
-34.82
-29.03
20
A
SER
13
85.99
65.09
20
A
LYS
19
-34.16
-20.62
20
A
LYS
25
-54.97
104.96
20
A
PRO
26
-45.87
93.37
20
A
ALA
28
-67.31
-170.72
20
A
TRP
29
38.21
73.60
20
A
THR
30
159.22
138.51
20
A
CYS
32
-101.65
-167.87
SOLUTION STRUCTURE OF DEFENSIN-LIKE PEPTIDE-2 (DLP-2) FROM PLATYPUS VENOM
1
N
N
A
ALA
8
A
ALA
8
HELX_P
A
SER
13
A
SER
13
1
1
6
disulf
2.029
A
CYS
9
A
SG
CYS
9
1_555
A
CYS
39
A
SG
CYS
39
1_555
disulf
2.030
A
CYS
16
A
SG
CYS
16
1_555
A
CYS
32
A
SG
CYS
32
1_555
disulf
2.030
A
CYS
24
A
SG
CYS
24
1_555
A
CYS
40
A
SG
CYS
40
1_555
TOXIN
HELIX, ANTIPARALLEL BETA-SHEET, TOXIN
DLP2_ORNAN
UNP
1
1
P82140
1
42
1D6B
1
42
P82140
A
1
1
42
2
anti-parallel
A
VAL
15
A
VAL
15
A
ASP
18
A
ASP
18
A
GLN
37
A
GLN
37
A
CYS
40
A
CYS
40
1
P 1